TollereBio Email Formats

Biotechnology Research • • 1-10 Employees

Key Contact at TollereBio

Hans Lien

Co-founder & COO

Company overview

Headquarters	XX
NAICS	541714
Founded	2023
Employees	1-10

About TollereBio

TollereBio was founded to commercialize the BECC Technology planform for adjuvant development invented by Dr. Robert K. Ernst at the University of Maryland, Baltimore. The BECC platform enables quick and efficient engineering of lipid A mimetics for identification of new TLR4 adjuvants with customized immunostimulatory properties. Our team of experienced industry veterans is excited to offer accessible, cost-effective vaccine adjuvants that can have a positive impact on global human health.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

TollereBio has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

TollereBio has never raised funding before.

Frequently asked questions

TollereBio is located in XX.

TollereBio was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

TollereBio has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at TollereBio

Hans Lien

Co-founder & COO

4.8

40,000 users